Page last updated: 2024-08-21

thymoquinone and Fatty Liver, Nonalcoholic

thymoquinone has been researched along with Fatty Liver, Nonalcoholic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Lei, L; Wang, Z; Zhang, D; Zhang, Y1
Hao, Y; Wang, F; Wu, Y; Yao, W; Yu, D; Zhang, X1
Abdel-Hamid, AAHM; Ayuob, NN; Helal, GMM; Mubarak, WA1
Abd Al Haleem, EN; Awad, AS; El-Bakly, WM; Sherief, MA1

Other Studies

4 other study(ies) available for thymoquinone and Fatty Liver, Nonalcoholic

ArticleYear
Thymoquinone attenuates hepatic lipid accumulation by inducing autophagy via AMPK/mTOR/ULK1-dependent pathway in nonalcoholic fatty liver disease.
    Phytotherapy research : PTR, 2023, Volume: 37, Issue:3

    Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Diet, High-Fat; Humans; Intracellular Signaling Peptides and Proteins; Lipid Metabolism; Lipids; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; TOR Serine-Threonine Kinases

2023
Protective role of thymoquinone in hyperlipidemia-induced liver injury in LDL-R
    BMC gastroenterology, 2023, Aug-11, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury, Chronic; Cholesterol; Hyperlipidemias; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease

2023
Thymoquinone reverses nonalcoholic fatty liver disease (NAFLD) associated with experimental hypothyroidism.
    Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2019, Volume: 60, Issue:2

    Topics: Animals; Benzoquinones; Disease Models, Animal; Hypothyroidism; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar

2019
Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis.
    Naunyn-Schmiedeberg's archives of pharmacology, 2016, Volume: 389, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Benzoquinones; Diet, High-Fat; Hepatitis; Inflammation Mediators; Insulin Resistance; Interleukin-10; Lipids; Liver; Liver Cirrhosis, Experimental; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Tumor Necrosis Factor-alpha

2016